D2 Receptors May Modulate the Function of the Striatal Transporter for Dopamine: Kinetic Evidence from Studies In Vitro and In Vivo

Abstract: Recently it was hypothesized by others that the D2dopamine receptor can regulate the uptake of dopamine. However, the evidence in support of this hypothesis, although compelling, was not based on observations related to direct measures of the kinetic activity of the transporter itself. Here kinetic evidence in support of this hypothesis is shown. The apparent time‐resolved initial velocity of the transport of 1.0 μM dopamine into striatal suspensions, measured using rotating disk electrode voltammetry, was found to increase in the presence of the D2 receptor agonist, quinpirole, at 100 μM. This effect was reversed by sulpiride. In separate studies it was shown that acute and chronic treatments with haloperidol at 0.5 mg/kg, i.p., reduced the reuptake transport of dopamine in vivo following intrastriatal stimulation of its release by K+. Thus, it appears that D2 receptors may influence the functioning of the striatal transporter for dopamine. These results are consistent with a model in which presynaptically released dopamine may feed back onto the function of its transporter to increase the velocity of the clearance of synaptic dopamine following an action potential, suggesting the existence of a mechanism, in addition to release and synthesis modulation, for fine‐tuning dopaminergic chemical signaling.

[1]  E. Richelson,et al.  Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. , 1984, European journal of pharmacology.

[2]  C. Shaar,et al.  Relative potency of LY141865 at dopamine DA2 and histamine H2 receptors. , 1983, European journal of pharmacology.

[3]  L. Parsons,et al.  Co‐Administration of the D2 Antagonist Pimozide Inhibits Up‐Regulation of Dopamine Release and Uptake Induced by Repeated Cocaine , 1993, Journal of neurochemistry.

[4]  P. Garris,et al.  Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum , 1992, Neuroscience.

[5]  J. O. Schenk,et al.  A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine. , 1992, Biochemical pharmacology.

[6]  R. Wightman,et al.  Monitoring the Stimulated Release of Dopamine with In Vivo Voltammetry. I: Characterization of the Response Observed in the Caudate Nucleus of the Rat , 1984, Journal of neurochemistry.

[7]  J. O. Schenk,et al.  Effects of acute and chronic systemic administration of some typical antipsychotic drugs on turnover of dopamine and potassium ion-induced release of dopamine in the striatum of the rat in vivo , 1991, Neuropharmacology.

[8]  B J Hoffer,et al.  Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. , 1992, The Journal of pharmacology and experimental therapeutics.

[9]  R. M. Krupka,et al.  Kinetics of inhibition of transport systems. , 1983, International review of cytology.

[10]  B. Bunney,et al.  Quantitative Interpretations of In Vivo Chronoamperometry , 1987 .

[11]  C. Rutledge,et al.  Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine. , 1982, Biochemical pharmacology.

[12]  L. Iversen,et al.  Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum. , 1976, Molecular pharmacology.

[13]  C. Rutledge,et al.  Evidence for carrier-mediated efflux of dopamine from corpus striatum. , 1982, Biochemical pharmacology.

[14]  J. O. Schenk,et al.  Blockade of dopamine autoreceptors by haloperidol and the apparent dynamics of potassium-stimulated endogenous release of dopamine from and reuptake into striatal suspensions in the rat , 1992, Neuropharmacology.

[15]  A. Cho,et al.  Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. , 1979, The Journal of pharmacology and experimental therapeutics.

[16]  J. Kebabian,et al.  Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor , 1981, Nature.

[17]  R. M. Krupka,et al.  The membrane valve: a consequence of asymmetrical inhibition of membrane carriers. I. Equilibrating transport systems. , 1979, Biochimica et biophysica acta.

[18]  I. Hanbauer,et al.  Comparison of [3H]WIN 35,428 Binding, a Marker for Dopamine Transporter, in Embryonic Mesencephalic Neuronal Cultures with Striatal Membranes of Adult Rats , 1993, Journal of neurochemistry.

[19]  R. Wightman,et al.  Monitoring the Stimulated Release of Dopamine with In Vivo Voltammetry. II: Clearance of Released Dopamine from Extracellular Fluid , 1984, Journal of neurochemistry.

[20]  J. Hyttel Inhibition of [3H]dopamine accumulation in rat striatal synaptosomes by psychotropic drugs. , 1978, Biochemical pharmacology.

[21]  J. O. Schenk,et al.  Rotating disk voltammetric measurements in neurobiology and neuropharmacology , 1990 .